EP0598813A4 - Immunostimulation. - Google Patents

Immunostimulation.

Info

Publication number: EP0598813A4
Authority: EP; European Patent Office
Prior art keywords: immunostimulation
Prior art date: 1991-08-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP9292917802A

Other versions

EP0598813A1 (en

Inventor

Andrew Francis Geczy

Gregory John Russell-Jones

Stephen John Duncan Bell

David Albert Cooper

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Biotech Australia Pty Ltd

St Vincents Hospital Sydney Ltd

Original Assignee

Biotech Australia Pty Ltd

St Vincents Hospital Sydney Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-08-13

Filing date

1992-08-10

Publication date

1994-09-14

1992-08-10 Application filed by Biotech Australia Pty Ltd, St Vincents Hospital Sydney Ltd filed Critical Biotech Australia Pty Ltd

1994-06-01 Publication of EP0598813A1 publication Critical patent/EP0598813A1/en

1994-09-14 Publication of EP0598813A4 publication Critical patent/EP0598813A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Mycology (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

EP9292917802A 1991-08-13 1992-08-10 Immunostimulation. Withdrawn EP0598813A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
AUPK772591		1991-08-13
AU7725/91		1991-08-13
PCT/AU1992/000423 WO1993003762A1 (en)	1991-08-13	1992-08-10	Immunostimulation

Publications (2)

Publication Number	Publication Date
EP0598813A1 EP0598813A1 (en)	1994-06-01
EP0598813A4 true EP0598813A4 (en)	1994-09-14

Family

ID=3775617

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP9292917802A Withdrawn EP0598813A4 (en)	1991-08-13	1992-08-10	Immunostimulation.

Country Status (10)

Country	Link
EP (1)	EP0598813A4 (en)
JP (1)	JPH07500819A (en)
CA (1)	CA2115424A1 (en)
CZ (1)	CZ28294A3 (en)
HU (2)	HUT70269A (en)
NZ (1)	NZ243929A (en)
OA (1)	OA09885A (en)
SK (1)	SK13494A3 (en)
WO (1)	WO1993003762A1 (en)
ZA (1)	ZA926021B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1210114A4 (en) *	1999-08-20	2004-01-02	Gen Hospital Corp	Outer membrane protein a, peptidoglycan-associated lipoprotein, and murein lipoprotein as therapeutic targets for treatment of sepsis
US7117033B2 (en)	2000-05-08	2006-10-03	Brainsgate, Ltd.	Stimulation for acute conditions
US7561919B2 (en)	2002-11-14	2009-07-14	Brainsgate Ltd.	SPG stimulation via the greater palatine canal
US8010189B2 (en)	2004-02-20	2011-08-30	Brainsgate Ltd.	SPG stimulation for treating complications of subarachnoid hemorrhage
US8055347B2 (en)	2005-08-19	2011-11-08	Brainsgate Ltd.	Stimulation for treating brain events and other conditions
US9233245B2 (en)	2004-02-20	2016-01-12	Brainsgate Ltd.	SPG stimulation
JP5731198B2 (en)	2007-09-27	2015-06-10	イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅＴｅｃｈｎｏｌｏｇｉｅｓＩｎｃ．	Use of liposomes in carriers containing a continuous hydrophobic phase for delivery of polynucleotides in vivo
AU2009253780B2 (en)	2008-06-05	2014-08-14	Immunovaccine Technologies Inc.	Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
CN113876945A (en)	2011-10-06	2022-01-04	免疫疫苗技术有限公司	Liposome composition comprising adjuvant for activating or increasing TLR2 activity and application thereof
US9675796B2 (en)	2013-11-10	2017-06-13	Brainsgate Ltd.	Implant and delivery system for neural stimulator
EP3093043B1 (en)	2015-05-13	2018-11-14	Brainsgate Ltd.	Implant and delivery system for neural stimulator

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1987006590A1 (en) *	1986-04-21	1987-11-05	Bioenterprises Pty. Ltd.	Immunopotentiation
WO1992005192A1 (en) *	1990-09-18	1992-04-02	Biotech Australia Pty. Limited	T-cell epitopes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0109688A3 (en) *	1982-11-23	1986-12-03	The Wellcome Foundation Limited	Improved complexes, processes for obtaining them and formulations containing such complexes
US4459286A (en) *	1983-01-31	1984-07-10	Merck & Co., Inc.	Coupled H. influenzae type B vaccine
JPH0720878B2 (en) *	1983-11-21	1995-03-08	ザウエルカムフアウンデ−シヨンリミテツド	Improved conjugates, processes for their production and formulations containing the conjugates
NL8403195A (en) *	1984-10-19	1986-05-16	Nederlanden Staat	IMMUNOGENIC COMPLEXES AND VACCINES CONTAINING THESE.
CA1340888C (en) *	1988-09-01	2000-02-01	Algis Anilionis	Vaccines and diagnostic assays for haemophilus influenzae

1992
- 1992-08-10 EP EP9292917802A patent/EP0598813A4/en not_active Withdrawn
- 1992-08-10 WO PCT/AU1992/000423 patent/WO1993003762A1/en not_active Ceased
- 1992-08-10 SK SK134-94A patent/SK13494A3/en unknown
- 1992-08-10 HU HU9400233A patent/HUT70269A/en unknown
- 1992-08-10 CZ CS94282A patent/CZ28294A3/en unknown
- 1992-08-10 CA CA002115424A patent/CA2115424A1/en not_active Abandoned
- 1992-08-10 JP JP5503956A patent/JPH07500819A/en active Pending
- 1992-08-11 ZA ZA926021A patent/ZA926021B/en unknown
- 1992-08-12 NZ NZ243929A patent/NZ243929A/en unknown
1994
- 1994-02-10 OA OA60472A patent/OA09885A/en unknown
- 1994-12-07 HU HU94P/P00050P patent/HU210605A9/en unknown

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1987006590A1 (en) *	1986-04-21	1987-11-05	Bioenterprises Pty. Ltd.	Immunopotentiation
WO1992005192A1 (en) *	1990-09-18	1992-04-02	Biotech Australia Pty. Limited	T-cell epitopes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
S. CROFT ET AL.: "TraT: A POWERFUL CARRIER MOLECULE FOR THE STIMULATION OF IMMUNE RESPONSES TO PROTEIN AND PEPTIDE ANTIGENS.", JOURNAL OF IMMUNOLOGY., vol. 146, no. 3, 1 February 1991 (1991-02-01), BALTIMORE US, pages 793 - 798 *
See also references of WO9303762A1 *

Also Published As

Publication number	Publication date
WO1993003762A1 (en)	1993-03-04
ZA926021B (en)	1993-03-26
HUT70269A (en)	1995-09-28
HU210605A9 (en)	1995-05-29
HU9400233D0 (en)	1994-05-30
CZ28294A3 (en)	1994-05-18
OA09885A (en)	1994-09-15
JPH07500819A (en)	1995-01-26
NZ243929A (en)	1994-12-22
CA2115424A1 (en)	1993-03-04
EP0598813A1 (en)	1994-06-01
SK13494A3 (en)	1994-09-07

Publication	Publication Date	Title
DE69107059D1 (en)	1995-03-09	Sigma-delta-modulator.
ZA92908B (en)	1993-08-09	Compounds.
AR244753A1 (en)	1993-11-30	Azo-colouring.
EP0597463A3 (en)	1996-11-06	Thermotherapiesonde.
EP0580285A3 (en)	1995-05-03	Auto-reclosers.
DE69111595D1 (en)	1995-08-31	Squarylium- und crokonyliumfarbstoffe.
DE69104185D1 (en)	1994-10-27	Luftreservoir.
DE69112211D1 (en)	1995-09-21	Luftreinigungsvorrichtung.
ZA929517B (en)	1993-07-12	Compounds.
DE59204008D1 (en)	1995-11-16	Trachealstent.
ZA927792B (en)	1993-04-20	Anti-alpha6-integrin-antibodies.
ZA926482B (en)	1993-03-08	Cyanophenylpyrroles.
DE69106281D1 (en)	1995-02-09	Phenanthrenderivat.
EP0598813A4 (en)	1994-09-14	Immunostimulation.
ZA929590B (en)	1994-06-10	Diphenylsulphides.
DE69102644D1 (en)	1994-07-28	Demodulationsreferenzsignalquelle.
OA09716A (en)	1993-08-30	Benzoxaiole derivatives.
DE69205795D1 (en)	1995-12-07	Mesoprotheseunterlage.
EP0576606A4 (en)	1994-11-23	Residual protease-iii.
DE69114491D1 (en)	1995-12-14	Olefincopolymere.
DE69110012D1 (en)	1995-06-29	Linienerkennungsverfahren.
EP0599191A3 (en)	1995-02-08	Speed-governor-circuit.
ZA925185B (en)	1993-04-29	Dithianes.
DE69203865D1 (en)	1995-09-07	Thermo-transferdrucksystem.
ZA929820B (en)	1993-06-23	Heisswinderschieber.

Legal Events

Date	Code	Title	Description
1994-04-15	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1994-06-01	17P	Request for examination filed	Effective date: 19940304
1994-06-01	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL SE
1994-09-14	A4	Supplementary search report drawn up and despatched	Effective date: 19940728
1994-09-14	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL SE
1996-08-14	17Q	First examination report despatched	Effective date: 19960702
1997-08-06	18D	Application deemed to be withdrawn	Effective date: 19970114